What To Expect From Icecure Medical Ltd (ICCM) Q4 2025 Earnings [Yahoo! Finance]
IceCure Medical Ltd. - Ordinary Shares (ICCM)
Company Research
Source: Yahoo! Finance
The consensus estimate for Q4 2025 revenue is $1.90 million, and the earnings are expected to come in at -$0.05 per share. The full year 2025's revenue is expected to be $3.87 million and the earnings are expected to be -$0.22 per share. More detailed estimate data can be found on the Forecast page Icecure Medical Ltd ( NASDAQ:ICCM ) Estimates Trends Warning! GuruFocus has detected 5 Warning Signs with ICCM. Is ICCM fairly valued? Test your thesis with our free DCF calculator. Revenue estimates for Icecure Medical Ltd ( NASDAQ:ICCM ) have increased from $3.67 million to $3.87 million for the full year 2025 and remained flat at $5.00 million for 2026 over the past 90 days. Earnings estimates for Icecure Medical Ltd ( NASDAQ:ICCM ) have remained flat at -$0.22 per share for the full year 2025 and at -$0.15 per share for 2026 over the past 90 days. Icecure Medical Ltd ( NASDAQ:ICCM ) Reported History In the previous quarter of 2025-09-30, Icecure Medical Ltd's ( NASDAQ:ICCM )
Show less
Read more
Impact Snapshot
Event Time:
ICCM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ICCM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ICCM alerts
High impacting IceCure Medical Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
ICCM
News
- U.S. FDA Approves IceCure's Post-Marketing "ChoICE" Study for ProSense® Cryoablation in the Local Treatment of Low-Risk Breast Cancer [Yahoo! Finance]Yahoo! Finance
- U.S. FDA Approves IceCure's Post-Marketing "ChoICE" Study for ProSense® Cryoablation in the Local Treatment of Low-Risk Breast CancerPR Newswire
- IceCure Medical to Report 2025 Full Year Financial and Operating Results on March 17, 2026PR Newswire
- American Society of Breast Surgeons (ASBrS) Resource Guide Update Recommends Cryoablation for Low-Risk Breast Cancer [Yahoo! Finance]Yahoo! Finance
- American Society of Breast Surgeons (ASBrS) Resource Guide Update Recommends Cryoablation for Low-Risk Breast CancerPR Newswire
ICCM
Earnings
- 8/13/25 - Miss
ICCM
Sec Filings
- 3/16/26 - Form F-3/A
- 3/11/26 - Form 6-K
- 3/9/26 - Form 6-K
- ICCM's page on the SEC website